Biocon Ltd.
| BSE: 532523 | Sector: Health care |
| NSE: BIOCON | ISIN Code: INE376G01013 |
| BSE 00:00 | 24 Apr | Biocon Ltd is not traded on BSE in the last 30 days |
| NSE 05:30 | 01 Jan | Biocon Ltd is not traded on NSE in the last 30 days |
| OPEN | 342.05 |
| PREVIOUS CLOSE | 347.55 |
| VOLUME | 341566 |
| 52-Week high | 367.80 |
| 52-Week low | 211.30 |
| P/E | 141.21 |
| Mkt Cap.(Rs cr) | 42,870 |
| Buy Price | 356.30 |
| Buy Qty | 100.00 |
| Sell Price | 357.25 |
| Sell Qty | 51.00 |
About Biocon Ltd.
Biocon Limited is India's largest and fully-integrated innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin) BASALOG (Glargine) CANMAb (Trastuzumab) BIOMAb-EGFR (Nimotuzumab) KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab) a 'first in class' anti-CD6 monoclonal antibody. The company has a rich pipeline of Biosimilars and Novel Biologics at various stages of deve...> More
Biocon Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr)
|
42,870 | |
| EPS - TTM | () |
[*S] | 2.53 |
| P/E Ratio | (X) | [*S] | 141.21 |
| Face Value | () |
5 | |
| Latest Dividend | (%) | 10.00 | |
| Latest Dividend Date | 18 Jul 2019 | ||
| Dividend Yield | (%) | 0.14 | |
| Book Value / Share | () |
[*S] | 60.94 |
| P/B Ratio | () |
[*S] | 5.86 |
News
-
Biocon's Semglee, an insulin glargine injection, gets US FDA approval
-
Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018
-
Biocon rallies 6%, hits record high on favourable ruling from US PTAB
-
Once the stock breakout, wait for the rally to sustain with decent volumes
-
Confused about when to buy a stock? Here's what you need to know
Biocon Ltd - Financial Results
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 1748.1 | 1540.8 | 13.45 |
| Other Income | 35.8 | 43.9 | -18.45 |
| Total Income | 1783.9 | 1584.7 | 12.57 |
| Total Expenses | 1307.1 | 1160.1 | 12.67 |
| Operating Profit | 476.8 | 424.6 | 12.29 |
| Net Profit | 230.3 | 243.2 | -5.3 |
| Equity Capital | 600 | 300 | - |
Biocon Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Dr Reddy's Labs | 4002.25 | -0.61 | 66509.39 |
| Divi's Lab. | 2428.65 | 0.28 | 64468.51 |
| Cipla | 599.60 | 2.21 | 48342.75 |
| Biocon | 357.25 | 2.79 | 42870.00 |
| Torrent Pharma. | 2431.60 | 0.43 | 41147.54 |
| Lupin | 877.25 | 6.73 | 39743.81 |
| Aurobindo Pharma | 623.95 | -0.79 | 36557.23 |
Biocon Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherBiocon Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 0.48% | 0.61% | -0.83% | -1.21% |
| 1 Month | 31.90% | 31.88% | 17.44% | 17.35% |
| 3 Month | 21.33% | 21.42% | -24.72% | -25.26% |
| 6 Month | 45.85% | 45.85% | -19.72% | -20.96% |
| 1 Year | 16.44% | 16.53% | -19.79% | -21.93% |
| 3 Year | 101.10% | 101.25% | 5.64% | -0.69% |
Biocon Ltd - STOCK STRENGTH
| Today's Low/High | 339.45 |
|
359.85 |
| Week Low/High | 339.45 |
|
368.00 |
| Month Low/High | 254.40 |
|
368.00 |
| YEAR Low/High | 211.30 |
|
368.00 |
| All TIME Low/High | 14.42 |
|
368.00 |
Quick Links for Biocon:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
